← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2015Last known activity
Jun 30, 2025
Timeline
2010s
- Jun 1, 2011
Ascletis Pharmaceuticals Co., Ltd.— Founded
Drugs by trial phase (26 distinct, 36 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (12 own, 0 via acquisition)
Indications
Recent trials (47)
- NCT07024602Lead sponsorPhase 1Jun 30, 2025
- NCT07002905Lead sponsorPhase 2Jun 30, 2025
- NCT06972992Lead sponsorPhase 1Apr 18, 2025
- NCT06679959Lead sponsorPhase 1Sep 16, 2024
- NCT06680440Lead sponsorPhase 1Aug 26, 2024
- NCT06427590Lead sponsorPhase 1Jul 13, 2024
- NCT06248008Lead sponsorPhase 3Apr 18, 2024
- NCT06192264Lead sponsorPhase 3Jan 23, 2024
- NCT05718518Lead sponsorPhase 1Jan 13, 2023
- NCT05596045Lead sponsorPhase 1Nov 28, 2022
- NCT05523141Lead sponsorPhase 1Oct 7, 2022
- NCT05287399CollaboratorPhase 1Aug 2, 2022
- NCT05330143Lead sponsorPhase 2Jun 28, 2022
- NCT05104125Lead sponsorPhase 2Dec 20, 2021
- NCT05107778Lead sponsorPhase 2Dec 17, 2021
Details
- Founded
- Chapel Hill, NC, US Jun 1, 2011
- Last known activity
- Jun 30, 2025